NCT05235711View on ClinicalTrials.gov

The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Fungal InfectionCandidiasis
Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05235711 - The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis | Biotech Hunter | Biotech Hunter